CALCA and neuropathic pain: However, another group found that intrathecal injection of CGRP receptor antagonists (CGRP 8-37 orolcegepant) attenuated mechanical hypersensitivity in a female-specific manner in both a hyperalgesic priming model and at the chronic phase of the SNI neuropathic pain model (Paige et al., 2022).